Vitamin D and Its Metabolites Deficiency in Acute Coronary Syndrome Patients Undergoing Coronary Angiography: A Case-Control Study.
Hussein M IsmailAbeer S AlgrafiOsama AmoudiSameh AhmedSultan S Al ThagfanHassan ShoraMohammed AljohaniMohammed AlmutairiFahad AlharbiAbdullah AlhejailiMajed AlamriAbdullah MuhawishAyat RoushdyPublished in: Vascular health and risk management (2021)
There was a strong association between vitamin D and all its metabolites with ACS. Significantly, low 25(OH)D and 1,25(OH)2D predicted ACS, but vitamin D2 and D3 did not. Large randomized controlled trials are needed to verify the beneficial values of vitamin D supplementation in ACS patients.
Keyphrases
- acute coronary syndrome
- percutaneous coronary intervention
- antiplatelet therapy
- patients undergoing
- end stage renal disease
- randomized controlled trial
- ms ms
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- clinical trial
- systematic review
- coronary artery disease
- patient reported outcomes
- smoking cessation
- atrial fibrillation
- replacement therapy
- patient reported